BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

Abstract Immunogenicity related to treatment with TNF inhibitors (TNFi) is one of the causes for the decreased attainment of clinical response in patients with rheumatoid arthritis (RA). The B-cell activating factor (BAFF) may be playing a role in the development of immunogenicity. The objective of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Borja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, Ioannis Parodis, Johanna E. Gehin, Ana Martínez-Feito, Marta Novella-Navarro, Araceli Mezcua, David J. Warren, Pilar Nozal, Dora Pascual-Salcedo, Alejandro Balsa
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/23161f74c66b452fadeaadcaeff92d76
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/23161f74c66b452fadeaadcaeff92d76

Ejemplares similares